论文部分内容阅读
目的:探讨对稳定期慢性阻塞性肺疾病患者实施医院—社区—家庭协同管理的效果。方法:将209例COPD稳定期患者随机分为观察组和对照组,对照组采用常规社区管理方式,观察组实施医院—社区—家庭协同管理方式,整个管理周期为6个月,比较两组患者管理前后的肺功能、圣乔治呼吸问卷评分变化情况,并于管理结束后调查比较两组患者的疾病认知度、依从性以及满意度。结果:管理后两组患者的FEV1、FEV1百分数、FEV1/FVC指标明显高于管理前(P<0.05),且观察组明显高于对照组(P<0.05)。管理后两组患者的呼吸症状、活动受限、疾病影响、SGRQ总分均显著降低(P<0.05)。观察组呼吸症状、活动受限、SGRQ总分降低程度显著优于对照组,差异有统计学意义(P<0.05)。管理后观察组患者的疾病认知度、依从性、满意度均显著高于对照组,差异有统计学意义(P<0.05)。结论:实施医院—社区—家庭协同管理稳定期COPD患者,可延缓患者肺功能下降,有效提高患者生活质量,提高患者的管理效果。
Objective: To explore the effect of hospital-community-family collaborative management on patients with chronic obstructive pulmonary disease in stable phase. Methods: A total of 209 patients with stable COPD were randomly divided into observation group and control group. The control group was treated by the conventional community management method. The hospital-community-family collaborative management mode was implemented in the observation group. The whole management cycle was 6 months. Before and after the management of lung function, St. George’s Respiratory Questionnaire score changes, and after the end of the management survey to compare the two groups of patients awareness of disease, compliance and satisfaction. Results: The FEV1, FEV1 percentage and FEV1 / FVC of the two groups after management were significantly higher than those before the management (P <0.05), and the observation group was significantly higher than the control group (P <0.05). Respiratory symptoms, limited mobility, and disease effects, and SGRQ scores were significantly reduced in both groups (P <0.05). Observation group respiratory symptoms, limited activities, SGRQ total score was significantly better than the control group, the difference was statistically significant (P <0.05). After the management, the awareness, compliance and satisfaction of patients in the observation group were significantly higher than those in the control group, with significant difference (P <0.05). Conclusion: The implementation of hospital-community-family collaborative management of patients with stable COPD can delay the decline of pulmonary function, effectively improve the quality of life of patients and improve the management effect of patients.